Reconstruction of the midface using a Le Fort III advancement combined with a distraction osteogenesis device, performed without simultaneous intracranial surgery.
Verified May 8, 2026 · 5 sources ↓
- Medicare
- $2,210.14
- Total RVUs
- 66.17
- Global, days
- 90
- Region
- Other
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 5 cited references ↓
- Operative note must explicitly state that no intracranial procedure was performed, distinguishing 21159 from 21160.
- Identify the specific osteotomy pattern performed (Le Fort III level, zygomatic cuts, pterygomaxillary dysjunction).
- Document the type of distraction device placed — internal versus external — and initial activation parameters.
- Include the diagnosis driving medical necessity, such as syndromic craniosynostosis (e.g., Crouzon, Apert), with corresponding ICD-10 code.
- Record the surgical team composition; if a neurosurgeon was present but did not perform intracranial work, note that explicitly.
- Document preoperative imaging findings (CT with 3D reconstruction is standard) supporting the need for midface advancement.
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 5 cited references ↓
CPT 21159 describes Le Fort III midface advancement using distraction osteogenesis, performed without a concurrent intracranial procedure. The surgeon performs a Le Fort III osteotomy — separating the midface from the skull base — and places an internal or external distraction device that incrementally advances the midface over a postoperative activation period rather than achieving full correction acutely. The absence of intracranial work is what separates 21159 from 21160, and that distinction must be explicit in the operative note.
This is one of the highest-complexity craniofacial procedures in the CPT system. It typically involves a multidisciplinary team including craniofacial surgery and, in the pediatric setting, neurosurgery on standby. Even without intracranial entry, the operative scope includes zygomatic osteotomies, pterygomaxillary dysjunction, and hardware placement. The 90-day global period covers all routine postoperative activation visits, device monitoring, and distraction follow-up through day 90.
Billing this code in a hospital outpatient setting versus an ASC changes payment significantly — see the Site of Service comparison. Most payers require prior authorization and medical necessity documentation citing syndromic craniosynostosis or equivalent diagnosis. Surgeons performing this procedure under academic or institutional arrangements should confirm whether the professional component is separately billable or bundled under a teaching physician arrangement.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 42.06 |
| Practice expense RVU | 17.96 |
| Malpractice RVU | 6.15 |
| Total RVU | 66.17 |
| Medicare national rate | $2,210.14 |
| Global period | 90 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $2,210.14 |
HOPD (APC 5165) Hospital outpatient department | $6,048.05 |
ASC (PI J8) Ambulatory surgical center (freestanding) | $3,833.49 |
Common denial reasons
The recurring reasons claims for CPT 21159 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Missing documentation confirming absence of intracranial procedure — payers use this to question whether 21159 or 21160 applies.
- No prior authorization obtained before a non-emergent midface reconstruction procedure.
- Diagnosis code does not support medical necessity for a Le Fort III-level advancement in the payer's clinical criteria.
- Unbundling denial when distraction device placement is billed separately — device placement is integral to 21159.
- Teaching physician attestation absent or insufficient when procedure is performed at an academic center.
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What is the difference between 21159 and 21160?
02How does 21159 differ from 21154 and 21155?
03Can you separately bill for the distraction device hardware under 21159?
04What postoperative visits are covered in the 90-day global period?
05Can 21159 be billed with modifier 62 for co-surgeons?
06Is prior authorization required for 21159?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02cms.govhttps://www.cms.gov/medicare/coding-billing/national-correct-coding-initiative-ncci-edits/medicare-ncci-medically-unlikely-edits-mues
- 03cms.govhttps://www.cms.gov/files/document/chapter11cptcodes90000-99999final11.pdf
- 04fastrvu.comhttps://fastrvu.com/cpt/21159
- 05aaos.orghttps://www.aaos.org/quality/coding-and-reimbursement/
Mira AI Scribe
Mira's AI scribe captures the Le Fort III osteotomy level, distraction device type and placement site, pterygomaxillary dysjunction technique, and the explicit absence of intracranial entry from dictation. That last detail prevents the most common audit flag for 21159: reviewers checking whether 21160 (with intracranial) should have been billed instead. The scribe also pulls the syndromic diagnosis into the note to anchor medical necessity before prior authorization review begins.
See how Mira captures CPT 21159 documentation